DCGI

Timelines
Sputnik V Phase-II trials to have 100 volunteers: Dr. Reddy's

25 Oct 2020

Sputnik V Phase-II trials to have 100 volunteers: Dr. Reddy's

Phase II clinical trials for the Russian COVID-19 vaccine, Sputnik V, will have 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) has told Sputnik.

Coronavirus: Bharat Biotech aims to launch COVAXIN by June 2021

24 Oct 2020

Coronavirus: Bharat Biotech aims to launch COVAXIN by June 2021

Hyderabad-based pharmaceutical firm Bharat Biotech is expecting to launch its coronavirus vaccine candidate, COVAXIN, by June next year.

Coronavirus vaccine to reach 25 crore Indians by mid-2021: Government

04 Oct 2020

Coronavirus vaccine to reach 25 crore Indians by mid-2021: Government

The Indian government is planning to provide vaccines to roughly 25 crore people by July 2021, Union Health Minister Dr. Harsh Vardhan said on Sunday.

Coronavirus: What is the 'Feluda' test? How does it work?

21 Sep 2020

Coronavirus: What is the 'Feluda' test? How does it work?

The Drugs Controller General of India (DCGI) has approved for commercial launch of a CRISPR-based test for COVID-19, called 'Feluda'.

After setback, Serum allowed to resume Oxford's coronavirus vaccine trial

16 Sep 2020

After setback, Serum allowed to resume Oxford's coronavirus vaccine trial

Drugs Controller General of India (DCGI) Dr. VG Somani has permitted the Serum Institute of India (SII) to resume trial of the coronavirus vaccine candidate, being developed by the University of Oxford, revoking the last week's order that halted the process.

Coronavirus vaccine won't be available for all before 2024-end: Poonawalla

14 Sep 2020

Coronavirus vaccine won't be available for all before 2024-end: Poonawalla

Adar Poonawalla, the CEO of the Serum Institute of India (SII), that has taken up the mammoth task of mass-producing the vaccine for novel coronavirus, asserted that the vaccine will not be available for the entire world before the end of 2024.

AstraZeneca resumes clinical trials for COVID-19 vaccine after UK nod

12 Sep 2020

AstraZeneca resumes clinical trials for COVID-19 vaccine after UK nod

Late-stage clinical trials of a COVID-19 vaccine being developed by the drug firm AstraZeneca and the University of Oxford have resumed.

Coronavirus: Serum Institute ordered to halt recruitment for vaccine trial

12 Sep 2020

Coronavirus: Serum Institute ordered to halt recruitment for vaccine trial

The Drugs Controller General of India (DCGI) has ordered the Serum Institute of India (SII) to pause the recruitment of volunteers for Phase 2 and Phase 3 trials of the coronavirus vaccine, being developed by the University of Oxford and UK-pharma giant AstraZeneca.

Big setback: Serum pauses Oxford's coronavirus vaccine trial in India

10 Sep 2020

Big setback: Serum pauses Oxford's coronavirus vaccine trial in India

A day after deciding to not halt the trial of the coronavirus vaccine, developed by the University of Oxford in collaboration with UK-pharma giant AstraZeneca, the Serum Institute of India (SII) on Thursday said it was also pausing the process.

Bharat Biotech gets approval to test COVAXIN administration through skin

22 Aug 2020

Bharat Biotech gets approval to test COVAXIN administration through skin

Hyderabad-based Bharat Biotech has been allowed to conduct a trial to test administer its COVID-19 vaccine candidate through the skin (intradermal vaccine delivery).

Zydus Cadila's COVID-19 vaccine found safe, going into Phase-2 trial

05 Aug 2020

Zydus Cadila's COVID-19 vaccine found safe, going into Phase-2 trial

Indian drug company Zydus Cadila has completed early-stage human trials with its indigenously developed COVID-19 vaccine.

Coronavirus: How much would the vaccines cost?

30 Jul 2020

Coronavirus: How much would the vaccines cost?

As the coronavirus pandemic continues to surge, all hopes rest on the development of a vaccine to beat the virus.

NewsBytes Briefing: Russia accused of testing satellite-destroying technology, and more

24 Jul 2020

NewsBytes Briefing: Russia accused of testing satellite-destroying technology, and more

In a strange piece of news, Russia has been accused of testing "what would appear to be [an] actual in-orbit anti-satellite weaponry," BBC reported.

You can enroll for AIIMS's COVID-19 vaccine trials: Here's how

19 Jul 2020

You can enroll for AIIMS's COVID-19 vaccine trials: Here's how

India's indigenous COVID-19 vaccine candidate, COVAXIN, is set to go into human trials at AIIMS Delhi.

COVID-19: All about world's cheapest testing kit created by IIT-Delhi

18 Jul 2020

COVID-19: All about world's cheapest testing kit created by IIT-Delhi

Ever since the COVID-19 pandemic began, medical experts have been emphasizing on the importance of aggressive and timely testing for effective containment.

All you need to know about India's COVID-19 vaccines

09 Jul 2020

All you need to know about India's COVID-19 vaccines

As the coronavirus outbreak continues to surge worldwide, efforts to develop a vaccine have been expedited.

Expert panel sets conditions, ICMR's COVAXIN August-15 target looks unachievable

07 Jul 2020

Expert panel sets conditions, ICMR's COVAXIN August-15 target looks unachievable

On July 2, the Indian Council of Medical Research (ICMR) revealed its plans to launch COVAXIN, the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech and ICMR, by August 15.

Following globally-accepted norms, says ICMR over August 15 vaccine target

04 Jul 2020

Following globally-accepted norms, says ICMR over August 15 vaccine target

The Indian Council of Medical Research (ICMR) on Saturday said that it is acting in accordance with globally-accepted norms by setting a mid-August target for developing a COVID-19 vaccine.

India's second COVID-19 vaccine cleared for human trials: Details here

03 Jul 2020

India's second COVID-19 vaccine cleared for human trials: Details here

India is picking up pace to develop a preventive vaccine for COVID-19, the novel coronavirus disease.

India targets to launch first COVID-19 vaccine by August 15

03 Jul 2020

India targets to launch first COVID-19 vaccine by August 15

In a major development, the Indian Council of Medical Research (ICMR) has announced its plan to launch a COVID-19 vaccine for public use by August 15.

Coronavirus: 5 states to receive first batch of Hetero's COVIFOR

25 Jun 2020

Coronavirus: 5 states to receive first batch of Hetero's COVIFOR

Five states across India will be the first to receive Hetero Healthcare's COVID-19 drug, COVIFOR, the first generic brand of the experimental drug remdesivir.

Glenmark launches COVID-19 drug FabiFlu at Rs. 103 per tablet

20 Jun 2020

Glenmark launches COVID-19 drug FabiFlu at Rs. 103 per tablet

Glenmark Pharmaceuticals Ltd. launched the antiviral drug favipiravir on Saturday for the treatment of mild to moderate cases of COVID-19.

GSK recalls popular antacid Zinetac amid concerns over cancer-causing substance

26 Sep 2019

GSK recalls popular antacid Zinetac amid concerns over cancer-causing substance

Amid an ongoing probe into Ranitidine's reported cancer-causing impurities, GlaxoSmithKline Pharmaceuticals Limited (GSK) has recalled Ranitidine-based antacid Zinetac (150mg and 300mg) in India and other markets.

Increasing antibiotic resistance hindering treatment for typhoid, pneumonia, TB

22 Apr 2017

Increasing antibiotic resistance hindering treatment for typhoid, pneumonia, TB

It is now harder to treat even milder illnesses like typhoid due to increased resistance to antibiotics, doctors concurred.

Most bacteria in WHO's 'priority pathogen' list found in India

02 Mar 2017

Most bacteria in WHO's 'priority pathogen' list found in India

In bad news for India, most of the 12 superbugs in WHO's first ever list of antibiotic-resistant 'priority pathogens' exist here.

India drug regulator issue antibiotic warnings

18 Jan 2017

India drug regulator issue antibiotic warnings

On the heels of the recent death of an American women due to an antibiotic-resistant infection, the Drug Controller General of India (DCGI) has issued strict warnings.